Clinical Trial Update: A Trial of Capecitabine (Xeloda), Oxaliplatin and Irinotecan in Combination With Bevacizumab in 1st Line Treatment of Metastatic Colorectal Cancer

View source ↗

Summary

A clinical trial evaluating a first-line combination regimen of capecitabine, oxaliplatin, irinotecan, and bevacizumab for metastatic colorectal cancer; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Metastatic Colorectal Cancer | Status: UNKNOWN